AYTU BIOPHARMA, INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aytu Biopharma, Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q2 2024.
  • Aytu Biopharma, Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $829K, a 59.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $829K -$1.23M -59.6% Jun 30, 2024 10-K 2024-09-26
Q1 2024 $1.8M -$572K -24.2% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.13M -$542K -20.3% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $2.45M -$522K -17.5% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.05M -$1.22M -37.2% Jun 30, 2023 10-K 2024-09-26
Q1 2023 $2.37M -$1.19M -33.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.68M -$1.17M -30.4% Dec 31, 2022 10-Q 2023-02-21
Q3 2022 $2.98M -$850K -22.2% Sep 30, 2022 10-Q/A 2023-02-21
Q2 2022 $3.27M -$292K -8.2% Jun 30, 2022 10-K 2023-10-12
Q1 2022 $3.56M -$221K -5.84% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $3.85M +$3.53M +1138% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $3.83M +$3.49M +1045% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $3.56M +$2.93M +462% Jun 30, 2021 10-K 2022-09-27
Q1 2021 $3.78M +$3.11M +459% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $310K -$64.1K -17.1% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 $334K -$59.5K -15.1% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $634K +$634K Jun 30, 2020 10-K 2021-09-28
Q1 2020 $676K Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $375K Dec 31, 2019 10-Q 2020-02-14
Q3 2019 $394K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $0 Jun 30, 2019 10-K 2020-10-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.